Servier Romania maintains longstanding commitment to patients’ quality of life

Having been on a constant growth path recently, Servier Romania remains dedicated to improving people’s quality of life, with a focus on bringing the best solutions for Romanian patients. Michel Eschenbrenner, the company’s general manager, spoke to Business Review about Servier’s commitment to health.

By Anda Sebesi

What is your leadership style and how does it support your company’s performance?

Leadership is not something that can be learned the traditional way. The best way to learn how to lead teams is through practice; you need to succeed and fail and learn from your failures. This must come together with a lot of trust and guidance from the people who give you the opportunity to become a leader. You must learn how to become a source of inspiration, and your everyday actions must speak for themselves. This involves accepting and responding to feedback all the time, listening and following up on proposals, and most importantly, always taking care of your team. In my opinion, one should follow a few important principles: encourage transparency, share information, encourage strategic thinking at all levels of the organisation, and always be prepared to listen. Because leadership is not a trait that is owned by the leader himself; it is something that’s shared, where anyone can make a decisive point.

What were your main professional achievements in 2023?

Servier has been operating in Romania for more than 30 years and I am proud to say that we are very stable in delivering essential treatments for our patients, particularly in the area where we have longstanding experience—cardiovascular diseases. We are global leaders in cardiology (ranked 4th among pharmaceutical groups in cardiology and the 3rd most important pharmaceutical group in hypertension worldwide) and we follow the same path in Romania. In every month of 2023, close to 3 million patients were treated with one or more of Servier’s medicines. In terms of growth, we are on a constant upward path, which very positively translates into a more preventive approach Romanians are taking towards their conditions and, equally important, into a willingness to better control their chronic diseases. As a company that’s dedicated to health, we will continue to direct our efforts towards improving Romanians’ quality of life beyond the actual treatment solutions we provide.

What were the biggest challenges your business sector faced last year and how did you navigate them?

The challenges I’ll mention are impacting both our business sector and, more importantly, Romanian patients. We can place these under two main categories: achieving better financing of the healthcare system to cover the increasing demand for medical services and lifesaving treatments and ensuring more predictable, timely, and equitable access to innovative treatments for Romanian patients, to put them on equal footing with other European citizens. Medical innovation over the past few decades has shown that access to treatment can significantly reduce the need for expensive emergency room visits, surgeries, hospitalisations, and long-term care, while simultaneously prolonging life expectancy and improving quality of life. Innovative medicines have already significantly increased survival, in chronic diseases and previously untreatable cancers, treating genetic conditions for which there were no existing drugs and even eliminating some infectious diseases altogether. In summary, the use of innovative medicines can lead to a decrease in the overall costs associated with the healthcare system.

Goals for 2024:

Maintain Romanian patients’ access to our treatments for critical conditions such as cardiovascular diseases, diabetes, and cancer
Work with my team to continue making a constant positive impact in the community
Collaborate with both my colleagues and external authorities and partners to contribute to making

DMCA

PROTECTED